Dynamic contrast-enhanced magnetic resonance imaging of prostate cancer: A review of current methods and applications

Figure 5 Representative 3T data in a 54-year-old prostate cancer patient [presurgical prostate-specific antigen level, 4. 7 ng/mL; biopsy Gleason score, 7 (3 + 4)]. Pharmacokinetic parameter maps based on the semi-quantitative method and the Toft’s kinetic model. Parametric maps for the semi-quantitative parameters, including B: Peak-enhancement; C: Enhancement slope; D: Wash-out slope; E: Time-to-peak; and F: Intensity curve or contrast medium concentration at 60 s. Using the Toft’s kinetic model, the pharmacokinetic parameter maps for G K^trans and H v_e are shown.